Sylvia Adams

NYU Langone Health

Full Professor(heuristic)

Cancer Immunotherapy and Biomarkers · Oncology

h-index72
i10-index158
Publications349
Citations31,786

Grants

10 total · 0 active

NIH #7R01CA161891-04

Immunomodulation of breast cancer via TLR7 agonist imiquimod and radiotherapy.

Amount
$373K
Period
2011-09-21 → 2016-12-31
PIs
2
Est. capacity / PI
~0 students

Awarded at WEILL MEDICAL COLL OF CORNELL UNIV

NIH #5R01CA161891-02

Immunomodulation of breast cancer via TLR7 agonist imiquimod and radiotherapy.

Amount
$377K
Period
2011-09-21 → 2015-07-31
PIs
2
Est. capacity / PI
~0 students

Awarded at NEW YORK UNIVERSITY SCHOOL OF MEDICINE

NIH #1R01CA161891-01

Immunomodulation of breast cancer via TLR7 agonist imiquimod and radiotherapy.

Amount
$379K
Period
2011-09-21 → 2015-07-31
PIs
2
Est. capacity / PI
~0 students

Awarded at NEW YORK UNIVERSITY SCHOOL OF MEDICINE

Student capacity is a rough estimate from remaining award size, split equally among PIs. Actual funding decisions vary.

All Grants

10 total · 0 active

NIH #7R01CA161891-04

Immunomodulation of breast cancer via TLR7 agonist imiquimod and radiotherapy.

Amount
$373K
Period
2011-09-21 → 2016-12-31
PIs
2
Est. capacity / PI
~0 students

Awarded at WEILL MEDICAL COLL OF CORNELL UNIV

NIH #5R01CA161891-02

Immunomodulation of breast cancer via TLR7 agonist imiquimod and radiotherapy.

Amount
$377K
Period
2011-09-21 → 2015-07-31
PIs
2
Est. capacity / PI
~0 students

Awarded at NEW YORK UNIVERSITY SCHOOL OF MEDICINE

NIH #1R01CA161891-01

Immunomodulation of breast cancer via TLR7 agonist imiquimod and radiotherapy.

Amount
$379K
Period
2011-09-21 → 2015-07-31
PIs
2
Est. capacity / PI
~0 students

Awarded at NEW YORK UNIVERSITY SCHOOL OF MEDICINE

NIH #5R01CA161891-03

Immunomodulation of breast cancer via TLR7 agonist imiquimod and radiotherapy.

Amount
$353K
Period
2011-09-21 → 2015-04-30
PIs
2
Est. capacity / PI
~0 students

Awarded at NEW YORK UNIVERSITY SCHOOL OF MEDICINE

NIH #3R01CA161891-03S1

Immunomodulation of breast cancer via TLR7 agonist imiquimod and radiotherapy.

Amount
$206K
Period
2013-12-03 → 2014-12-31
PIs
2
Est. capacity / PI
~0 students

Awarded at NEW YORK UNIVERSITY SCHOOL OF MEDICINE

NIH #5K23CA125205-05

Augmenting Cancer Vaccine Therapy with TLR9 agonists

Amount
$138K
Period
2007-07-05 → 2013-06-30
PIs
1
Est. capacity / PI
~0 students

Awarded at NEW YORK UNIVERSITY SCHOOL OF MEDICINE

NIH #5K23CA125205-04

Augmenting Cancer Vaccine Therapy with TLR9 agonists

Amount
$138K
Period
2007-07-05 → 2012-06-30
PIs
1
Est. capacity / PI
~0 students

Awarded at NEW YORK UNIVERSITY SCHOOL OF MEDICINE

NIH #5K23CA125205-03

Augmenting Cancer Vaccine Therapy with TLR9 agonists

Amount
$138K
Period
2007-07-05 → 2012-06-30
PIs
1
Est. capacity / PI
~0 students

Awarded at NEW YORK UNIVERSITY SCHOOL OF MEDICINE

NIH #5K23CA125205-02

Augmenting Cancer Vaccine Therapy with TLR9 agonists

Amount
$138K
Period
2007-07-05 → 2012-06-30
PIs
1
Est. capacity / PI
~0 students

Awarded at NEW YORK UNIVERSITY SCHOOL OF MEDICINE

NIH #1K23CA125205-01A1

Augmenting Cancer Vaccine Therapy with TLR9 agonists

Amount
$138K
Period
2007-07-05 → 2012-06-30
PIs
1
Est. capacity / PI
~0 students

Awarded at NEW YORK UNIVERSITY SCHOOL OF MEDICINE

Career Trajectory

Research Cluster Map

Direct collaborators. Node size = influence, colour = community, dashed = past collaboration.

Potential Collaborators

Recent Publications

Last 2 years · showing 10 of 10
Open author page on OpenAlex →